Uncategorized

European markets close lower; Novo Nordisk down 20% after obesity drug results – CNBC

Posted on Author Comments Off on European markets close lower; Novo Nordisk down 20% after obesity drug results – CNBC
  1. European markets close lower; Novo Nordisk down 20% after obesity drug results  CNBC
  2. Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps  CNBC
  3. Ozempic maker’s shares plunge after failed weight-loss trial  Yahoo! Voices
  4. Novo Nordisk Shares Plunge After New Obesity Shot Disappoints  The Wall Street Journal
  5. Novo Nordisk Falls Most on Record After New Weight Drug Disappoints  Bloomberg